
|Articles|May 15, 2003
FDA seeks more information on Vitrase
The FDA is looking for more analysis of data before deciding whether to approve ISTA Pharmaceuticals' ovine hyaluronidase compound for the treatment of vitreous hemorrhage.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement

















